Kiromic Biopharma Inc KRBPQ
$0.00
Last Updated: Jul 15, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
KRBPQ Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Kiromic Biopharma Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Kiromic Biopharma Inc. Stock Analysis KRBPQ
United States Health Care Nano Cap Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The company is headquartered in Houston, Texas and currently employs 44 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing an allogeneic Gamma Delta T-cell therapy featuring proprietary end-to-end bioinformatic, artificial intelligence (AI) targeting and manufacturing technologies to address solid tumors. The company has five clinical programs to study its key product candidates: Deltacel-01, Alexis-ISO-1, Alexis-PRO-1, Isocel combination, and Procel combination. Deltacel is its first allogeneic, off-the-shelf GDT cell-based product in Phase I clinical-stage. Its Procel and Isocel product candidates consist of allogeneic, engineered, off-the-shelf GDT cells, and they are in the preclinical development stage. Its Isocel product candidate consists of engineered GDTs that target Mesothelin Isoform 2, a target that has been discovered and prioritized using its Diamond AI bio-informatic platform. Its Procel product candidate consists of engineered GDTs that target PD-L1.
Kiromic Biopharma Inc (KRBPQ) Chart
Financial Metrics & Statements of Kiromic Biopharma Inc (KRBPQ)
FAQ's for Kiromic Biopharma Inc (KRBPQ)
- As of August 2026, Kiromic Biopharma Inc KRBPQ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kiromic Biopharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kiromic Biopharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kiromic Biopharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kiromic Biopharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kiromic Biopharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Kiromic Biopharma Inc (KRBPQ)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
